Clinical Trials List
2019-02-23 - 2026-12-31
Phase III
Recruiting5
ICD-10N05.0
Unspecified nephritic syndrome with minor glomerular abnormality
ICD-10N05.1
Unspecified nephritic syndrome with focal and segmental glomerular lesions
ICD-10N05.6
Unspecified nephritic syndrome with dense deposit disease
ICD-10N05.7
Unspecified nephritic syndrome with diffuse crescentic glomerulonephritis
ICD-10N05.8
Unspecified nephritic syndrome with other morphologic changes
ICD-10N06.0
Isolated proteinuria with minor glomerular abnormality
ICD-10N06.1
Isolated proteinuria with focal and segmental glomerular lesions
ICD-10N06.6
Isolated proteinuria with dense deposit disease
ICD-10N06.7
Isolated proteinuria with diffuse crescentic glomerulonephritis
ICD-10N06.8
Isolated proteinuria with other morphologic lesion
ICD-10N07.0
Hereditary nephropathy, not elsewhere classified with minor glomerular abnormality
ICD-10N07.1
Hereditary nephropathy, not elsewhere classified with focal and segmental glomerular lesions
ICD-10N07.6
Hereditary nephropathy, not elsewhere classified with dense deposit disease
ICD-10N07.7
Hereditary nephropathy, not elsewhere classified with diffuse crescentic glomerulonephritis
ICD-10N07.8
Hereditary nephropathy, not elsewhere classified with other morphologic lesions
ICD-10N14.0
Analgesic nephropathy
ICD-10N14.1
Nephropathy induced by other drugs, medicaments and biological substances
ICD-10N14.2
Nephropathy induced by unspecified drug, medicament or biological substance
ICD-10N14.3
Nephropathy induced by heavy metals
ICD-10N14.4
Toxic nephropathy, not elsewhere classified
ICD-10N15.0
Balkan nephropathy
ICD-10N15.8
Other specified renal tubulo-interstitial diseases
ICD-9583.89
Nephritis and nephropathy, not specified as acute or chronic, with other specified pathological lesion in kidney
-
Trial Applicant
GEORGE CLINICAL ASIA PACIFIC LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 洪啟智 Division of Nephrology
- Yi wen chiu Division of Nephrology
- 黃道揚 Division of Nephrology
- 蔡哲嘉 Division of Nephrology
- Hung-Chun CHEN Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ming-Ju Wu Division of Nephrology
- 蔡尚峰 Division of Nephrology
- 徐佳鈿 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王智賢 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
13 participants
-
Global
280 participants
